Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chevalier

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|March 15, 2019
γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activationMathieu F Chevalier, Nupur Bhatnagar, Céline Didier, et al.
Frontiers in Immunology|April 16, 2019
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 PolarizationPerrine Bohner, Mathieu F Chevalier, Valérie Cesson, et al.
European Cells & Materials|September 5, 2015
A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy?F Chevalier, D Arnaud, E Henault, et al.
Journal for Immunotherapy of Cancer|October 7, 2021
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapyMarie Tourret, Nana Talvard-Balland, Marion Lambert, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatmentsSylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, et al.
JCI Insight|February 1, 2024
Human MAIT cells inhibit alloreactive T cell responses and protect against acute graft-versus-host diseaseNana Talvard-Balland, Marion Lambert, Mathieu F Chevalier, et al.
European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.
European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.
AIDS (London, England)|November 3, 2011
Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infectionGaël Petitjean, Mathieu F Chevalier, Feriel Tibaoui, et al.
Plos Pathogens|July 3, 2013
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocationMathieu F Chevalier, Gaël Petitjean, Catherine Dunyach-Rémy, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|March 15, 2019
γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activationMathieu F Chevalier, Nupur Bhatnagar, Céline Didier, et al.
Frontiers in Immunology|April 16, 2019
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 PolarizationPerrine Bohner, Mathieu F Chevalier, Valérie Cesson, et al.
European Cells & Materials|September 5, 2015
A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy?F Chevalier, D Arnaud, E Henault, et al.
Journal for Immunotherapy of Cancer|October 7, 2021
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapyMarie Tourret, Nana Talvard-Balland, Marion Lambert, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatmentsSylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, et al.
JCI Insight|February 1, 2024
Human MAIT cells inhibit alloreactive T cell responses and protect against acute graft-versus-host diseaseNana Talvard-Balland, Marion Lambert, Mathieu F Chevalier, et al.
European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.
European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.
AIDS (London, England)|November 3, 2011
Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infectionGaël Petitjean, Mathieu F Chevalier, Feriel Tibaoui, et al.
Plos Pathogens|July 3, 2013
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocationMathieu F Chevalier, Gaël Petitjean, Catherine Dunyach-Rémy, et al.
Pageof 12